|
Edgar G. Engleman
Managing Partner
Dr. Engleman is a founding member of Vivo Ventures, LLC (formerly BioAsia Investments), a healthcare/biotechnology venture capital management firm in Palo Alto, California.
Dr. Engleman is Professor of Medicine and Pathology at Stanford University
School of Medicine, where he oversees the Stanford Blood Center and
his own immunology research group. An editor of numerous scientific
journals and the inventor of multiple patented technologies, he co-founded
Cetus Immune (1981), Genelabs Technologies (1984), National Medical
Audit (1985), Dendreon Corporation (l992) and CellGate Technologies
(1998). Dr. Engleman currently serves on the boards of several private biotechnology
companies.
Dr. Engleman received his B.A. from Harvard University and his M.D.
from Columbia University School of Medicine.
|
Our Team
Dr. Frank Kung
Dr. Edgar G. Engleman
Dr. Albert Cha
Dr. Chen Yu
James Huang, MBA
James Zhao, MD, MBA
|
